MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
about
Propionibacterium acnes infection after shoulder surgeryA Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesSafety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis.Propionibacterium acnes: infection beyond the skin.Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.Bridging Small Molecules to Modified Bacterial Microparticles Using a Disulphide Linkage: MIS416 as a Cargo Delivery System.Therapeutic Advances and Future Prospects in Progressive Forms of Multiple SclerosisTargeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis.4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues.Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes.NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study.Innate IFN-γ ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression.Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(d,l-lactic acid) nanospheres.MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells
P2860
Q26775842-0B2D7071-F5D1-41B4-B045-48FAC77CD674Q28068709-DC040F89-FBEC-40F9-B2F7-D9C172D35166Q33692792-3DF3155D-38FE-4879-BF19-A65B41959D53Q34235765-D2BE3167-A069-40EB-8A8D-2351164C86A8Q35793791-1EA1BADF-E75A-4D13-AC60-80FFEB5297E9Q35875793-11873352-DD67-41A4-904F-8F120E2C74C7Q36484443-445FEF32-35E4-49FF-B646-4BF6FE36EC7BQ37539049-066B09A2-B7B0-4824-8016-1D0593AAD7A9Q41090290-2D72DE2D-4E0E-4ACE-A7DC-4390F4607174Q41126889-75A5CCBD-0F7B-4566-81A0-9400F0C5A5E0Q41893830-A4624EBB-3C14-4E0A-B3BE-1AF13535A15EQ46269946-5984D2D9-5201-4743-AF03-7E2A985325B5Q46749615-C9AFC881-40C5-4F68-B468-D81B4E233CABQ47103678-0570AFDF-8F75-4446-88EA-849C2A811348Q47871631-0D513C39-1877-4D6E-9C41-2224F0AF145FQ49641872-7E1502DC-FCF5-4D47-B7D6-BC961129586BQ55115817-456D3E0B-D15E-4385-872A-124A73BEB676Q58806291-8AE096E7-715E-4694-AE1A-DD21718E5911
P2860
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@ast
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@en
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@nl
type
label
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@ast
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@en
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@nl
prefLabel
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@ast
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@en
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@nl
P2093
P1433
P1476
MIS416, a non-toxic microparti ...... ross-priming and Th1 immunity.
@en
P2093
Chris J O'Loughlin
Colin M Hayman
Deborah A Knight
Gill A Webster
Rebecca C Girvan
P304
P356
10.1016/J.VACCINE.2010.10.040
P407
P577
2010-10-27T00:00:00Z